EQA Program 2022

Labquality’s external quality assessment program (EQAS) is aimed at medical laboratories and point-of-care testing sites. The program includes more than 170 clinically relevant external quality assessment schemes and it is fully compliant with ISO15189 standard requirements.


Subscription for 2022 is open

Please subscribe to the 2022 EQA programs before the end of November 2021 to ensure your participation in all needed EQA rounds. You can renew your subscription by contacting our local partner in your country. Direct customers of Labquality can renew their subscriptions on LabScala. If you need more information, please contact our customer service info@labquality.fi.


Changes in the 2022 program:


New schemes and products

2281 Interleukin-6
5851 Francisella tularensis, antibodies
5651 CMV and EBV, nucleic acid detection, quantitative
2753 Gastric biomarkers
2526 Ketones (beta-hydroxybutyrate), POCT
5562 Multiple Respiratory Virus nucleic acid detection
7807 Preanalytics, Pneumatic Sample Transport


Discontinued schemes and products

– 4238 Leucocyte differential count, 5-part, automated: Abacus

 – 2733 Erythrocyte sedimentation rate, iSED


Planned pilot schemes

Information about pilot contents and schedules will be announced later. Pilot schemes are EQA schemes under our product development.

All changes are listed in the Product Catalogue 2022 on page 5.
Please download the catalogue from the button below.


Contact us for more information

Pin It on Pinterest

Share This